228 related articles for article (PubMed ID: 23995783)
1. Macrophages mediate gemcitabine resistance of pancreatic adenocarcinoma by upregulating cytidine deaminase.
Weizman N; Krelin Y; Shabtay-Orbach A; Amit M; Binenbaum Y; Wong RJ; Gil Z
Oncogene; 2014 Jul; 33(29):3812-9. PubMed ID: 23995783
[TBL] [Abstract][Full Text] [Related]
2. Intracellular Cytidine Deaminase Regulates Gemcitabine Metabolism in Pancreatic Cancer Cell Lines.
Bjånes TK; Jordheim LP; Schjøtt J; Kamceva T; Cros-Perrial E; Langer A; Ruiz de Garibay G; Kotopoulis S; McCormack E; Riedel B
Drug Metab Dispos; 2020 Mar; 48(3):153-158. PubMed ID: 31871136
[TBL] [Abstract][Full Text] [Related]
3. Combined blockade of TGf-β1 and GM-CSF improves chemotherapeutic effects for pancreatic cancer by modulating tumor microenvironment.
Liu Q; Wu H; Li Y; Zhang R; Kleeff J; Zhang X; Cui M; Liu J; Li T; Gao J; Pan B; Wu W; Wang W; Zhou L; Guo J; Dai M; Zhang T; Liao Q; Lu Z; Zhao Y
Cancer Immunol Immunother; 2020 Aug; 69(8):1477-1492. PubMed ID: 32285172
[TBL] [Abstract][Full Text] [Related]
4. The necrosome promotes pancreatic oncogenesis via CXCL1 and Mincle-induced immune suppression.
Seifert L; Werba G; Tiwari S; Giao Ly NN; Alothman S; Alqunaibit D; Avanzi A; Barilla R; Daley D; Greco SH; Torres-Hernandez A; Pergamo M; Ochi A; Zambirinis CP; Pansari M; Rendon M; Tippens D; Hundeyin M; Mani VR; Hajdu C; Engle D; Miller G
Nature; 2016 Apr; 532(7598):245-9. PubMed ID: 27049944
[TBL] [Abstract][Full Text] [Related]
5. Possible antitumor activity of 1-(3-C-ethynyl-beta-D-ribo-pentofuranosyl)cytosine (ECyd, TAS-106) against an established gemcitabine (dFdCyd)-resistant human pancreatic cancer cell line.
Kazuno H; Sakamoto K; Fujioka A; Fukushima M; Matsuda A; Sasaki T
Cancer Sci; 2005 May; 96(5):295-302. PubMed ID: 15904471
[TBL] [Abstract][Full Text] [Related]
6. Deciphering the role of Enterococcus faecium cytidine deaminase in gemcitabine resistance of gallbladder cancer.
Jiang L; Zhang L; Shu Y; Zhang Y; Gao L; Qiu S; Zhang W; Dai W; Chen S; Huang Y; Liu Y
J Biol Chem; 2024 Apr; 300(4):107171. PubMed ID: 38492776
[TBL] [Abstract][Full Text] [Related]
7. Macrophage-organoid co-culture model for identifying treatment strategies against macrophage-related gemcitabine resistance.
Jiang S; Deng T; Cheng H; Liu W; Shi D; Yuan J; He Z; Wang W; Chen B; Ma L; Zhang X; Gong P
J Exp Clin Cancer Res; 2023 Aug; 42(1):199. PubMed ID: 37553567
[TBL] [Abstract][Full Text] [Related]
8. The pancreatic cancer immune tumor microenvironment is negatively remodeled by gemcitabine while TGF-β receptor plus dual checkpoint inhibition maintains antitumor immune cells.
Rana M; Kansal R; Chaib M; Teng B; Morrrison M; Hayes DN; Stanfill AG; Shibata D; Carson JA; Makowski L; Glazer ES
Mol Carcinog; 2022 Jun; 61(6):549-557. PubMed ID: 35319799
[TBL] [Abstract][Full Text] [Related]
9. Cytidine Deaminase Resolves Replicative Stress and Protects Pancreatic Cancer from DNA-Targeting Drugs.
Lumeau A; Bery N; Francès A; Gayral M; Labrousse G; Ribeyre C; Lopez C; Nevot A; El Kaoutari A; Hanoun N; Sarot E; Perrier M; Pont F; Cerapio JP; Fournié JJ; Lopez F; Madrid-Mencia M; Pancaldi V; Pillaire MJ; Bergoglio V; Torrisani J; Dusetti N; Hoffmann JS; Buscail L; Lutzmann M; Cordelier P
Cancer Res; 2024 Apr; 84(7):1013-1028. PubMed ID: 38294491
[TBL] [Abstract][Full Text] [Related]
10. Cytidine deaminase enzyme activity is a predictive biomarker in gemcitabine-treated cancer patients.
Abbaspour A; Dehghani M; Setayesh M; Tavakkoli M; Rostamipour HA; Ghorbani M; Ramzi M; Omidvari S; Moosavi F; Firuzi O
Cancer Chemother Pharmacol; 2023 Dec; 92(6):475-483. PubMed ID: 37668680
[TBL] [Abstract][Full Text] [Related]
11. Tetrahydrouridine inhibits cell proliferation through cell cycle regulation regardless of cytidine deaminase expression levels.
Funamizu N; Lacy CR; Fujita K; Furukawa K; Misawa T; Yanaga K; Manome Y
PLoS One; 2012; 7(5):e37424. PubMed ID: 22616006
[TBL] [Abstract][Full Text] [Related]
12. Pancreatic cancer cells render tumor-associated macrophages metabolically reprogrammed by a GARP and DNA methylation-mediated mechanism.
Zhang M; Pan X; Fujiwara K; Jurcak N; Muth S; Zhou J; Xiao Q; Li A; Che X; Li Z; Zheng L
Signal Transduct Target Ther; 2021 Oct; 6(1):366. PubMed ID: 34711804
[TBL] [Abstract][Full Text] [Related]
13. Stromal and therapy-induced macrophage proliferation promotes PDAC progression and susceptibility to innate immunotherapy.
Zuo C; Baer JM; Knolhoff BL; Belle JI; Liu X; Alarcon De La Lastra A; Fu C; Hogg GD; Kingston NL; Breden MA; Dodhiawala PB; Zhou DC; Lander VE; James CA; Ding L; Lim KH; Fields RC; Hawkins WG; Weber JD; Zhao G; DeNardo DG
J Exp Med; 2023 Jun; 220(6):. PubMed ID: 36951731
[TBL] [Abstract][Full Text] [Related]
14. Notch Signaling Regulates Immunosuppressive Tumor-Associated Macrophage Function in Pancreatic Cancer.
Yan W; Menjivar RE; Bonilla ME; Steele NG; Kemp SB; Du W; Donahue KL; Brown KL; Carpenter ES; Avritt FR; Irizarry-Negron VM; Yang S; Burns WR; Zhang Y; Pasca di Magliano M; Bednar F
Cancer Immunol Res; 2024 Jan; 12(1):91-106. PubMed ID: 37931247
[TBL] [Abstract][Full Text] [Related]
15. Nucleotide metabolism in cancer cells fuels a UDP-driven macrophage cross-talk, promoting immunosuppression and immunotherapy resistance.
Scolaro T; Manco M; Pecqueux M; Amorim R; Trotta R; Van Acker HH; Van Haele M; Shirgaonkar N; Naulaerts S; Daniluk J; Prenen F; Varamo C; Ponti D; Doglioni G; Ferreira Campos AM; Fernandez Garcia J; Radenkovic S; Rouhi P; Beatovic A; Wang L; Wang Y; Tzoumpa A; Antoranz A; Sargsian A; Di Matteo M; Berardi E; Goveia J; Ghesquière B; Roskams T; Soenen S; Voets T; Manshian B; Fendt SM; Carmeliet P; Garg AD; DasGupta R; Topal B; Mazzone M
Nat Cancer; 2024 Jun; ():. PubMed ID: 38844817
[TBL] [Abstract][Full Text] [Related]
16. A novel role of TGFBI in macrophage polarization and macrophage-induced pancreatic cancer growth and therapeutic resistance.
Zhou J; Lyu N; Wang Q; Yang M; Kimchi ET; Cheng K; Joshi T; Tukuli AR; Staveley-O'Carroll KF; Li G
Cancer Lett; 2023 Dec; 578():216457. PubMed ID: 37865162
[TBL] [Abstract][Full Text] [Related]
17. Common activation of canonical Wnt signaling in pancreatic adenocarcinoma.
Pasca di Magliano M; Biankin AV; Heiser PW; Cano DA; Gutierrez PJ; Deramaudt T; Segara D; Dawson AC; Kench JG; Henshall SM; Sutherland RL; Dlugosz A; Rustgi AK; Hebrok M
PLoS One; 2007 Nov; 2(11):e1155. PubMed ID: 17982507
[TBL] [Abstract][Full Text] [Related]
18. Dopamine improves chemotherapeutic efficacy for pancreatic cancer by regulating macrophage-derived inflammations.
Liu Q; Zhang R; Zhang X; Liu J; Wu H; Li Y; Cui M; Li T; Song H; Gao J; Zhang Y; Yang S; Liao Q
Cancer Immunol Immunother; 2021 Aug; 70(8):2165-2177. PubMed ID: 33454798
[TBL] [Abstract][Full Text] [Related]
19. Black Phosphorus as a Targeting PPAR-γ Agonist to Reverse Chemoresistance in Patient-derived Organoids, Mice, and Pancreatic Tumor Cells.
Jiang S; Liu W; Shi D; Cheng H; Deng T; Chen G; Ma L; Zhang X; Gong P
Adv Healthc Mater; 2023 Nov; 12(29):e2301324. PubMed ID: 37531231
[TBL] [Abstract][Full Text] [Related]
20. Notch signaling regulates immunosuppressive tumor-associated macrophage function in pancreatic cancer.
Yan W; Steele NG; Kemp SB; Menjivar RE; Du W; Carpenter ES; Donahue KL; Brown KL; Irizarry-Negron V; Yang S; Burns WR; Zhang Y; di Magliano MP; Bednar F
bioRxiv; 2023 Jan; ():. PubMed ID: 36711890
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
